LCI - Lannett Company, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LCI - Lannett Company, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Caruthers who wrote (41)	6/13/2007 1:30:35 PM
From: richardred	Read Replies (1) of 81

Competition, trumped again?. Bradley Launches Generic Adoxa Tuesday June 12, 12:54 pm ET Bradley Pharmaceuticals Launches Generic Version of Its Antibiotic Adoxa FAIRFIELD, N.J. (AP) -- Specialty drug maker Bradley Pharmaceuticals Inc. said Tuesday it launched a 150-milligram generic version of its antibiotic Adoxa, used primarily to treat acne. The company has a licensing and distribution agreement with Par Pharmaceutical Co. for the tablets. Par has been the company's exclusive partner for an authorized generic version of the drug since 2005. Other companies with generic versions of the drug, which is also used to treat gonorrhea, chlamydia, periodontitis and other infections, include Mylan Laboratories Inc. and Lannett Co. Those generic versions vary in doses from 50 milligrams to 150 milligrams. Shares of Bradley fell 26 cents to $20.39, while shares of Mylan fell 18 cents to $18.56 and shares of Lannett fell 7 cents to $6.44 in midday trading. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next